The original research pricing strategy caused controversy A few years ago, a group of oncologists wrote an editorial on drug prices, with the breakthrough tyrosine kinase inhibitor Gleevec (imatinib mesylate) as an example of extreme pricing practices. This has sparked a major discussion about the price and value of… Continue Reading Reflection on Gleevec pricing

“The reason why the medicine is expensive is because you bought the second medicine. The price of the first medicine is billions of dollars.” It is cheap to produce tablets and it is difficult to develop new drugs. This is every pharmaceutical circle. The basic logic that was instilled at… Continue Reading Gleevec’s cost and price

The birth of Gleevec is legendary and very touching. To understand the birth of a drug, we must first understand the disease that this drug treats. Gleevec is a medicine for the treatment of chronic myeloid leukemia, but not many people understand it in the early stages. We all know… Continue Reading The silver bullet that shot the Werewolf: the wonderful story behind the birth of Gleevec